Ads
related to: sanofi- How To Screen For T1D
Learn How To Screen
Patients For T1D
- Learn About T1D Treatment
Discover T1D Treatment for
Appropriate Patients
- Patient Support
Discover Support For Patients
On Their T1D Journey
- Patient Criteria
Learn How Patients Qualify
For This T1D Treatment
- How To Screen For T1D
Search results
GSK shares fall 9% in wake of Zantac court ruling
Pharmaceutical Technology via Yahoo Finance· 3 hours agoPfizer, Boehringer Ingelheim, Sanofi, and Patheon are also implicated in the cases. In 2020, the US Food and Drug Administration (FDA) ordered the...
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 4 days agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware
Bloomberg via Yahoo Finance· 24 hours ago(Bloomberg) -- GSK Plc shares plunged in the wake of a court ruling that the UK drugmaker, alongside...
EMA backs approving Sanofi's Dupixent for 'smoker's lungs', FDA extends review
Reuters via Yahoo News· 4 days agoFrench drugmaker Sanofi and its U.S. partner have been counting on expanding the use of the drug as...
Delaware judge lets more than 70,000 Zantac lawsuits go forward By Reuters
Investing.com· 1 day agoThe ruling on Friday by Judge Vivian Medinilla of the Delaware Superior Court in Wilmington is a...
French pharma Sanofi announces stock purchase plan for employees
dpa international via Yahoo Finance· 4 days agoFrench pharmaceutical firm Sanofi has announced its stock purchase plan for employees for this year....
Sanofi’s Chronic Lung Disease Drug Gets EU Regulator Backing
Bloomberg· 4 days agoSanofi’s Dupixent is close to being approved in Europe for use in helping patients with a chronic...
Sanofi’s CEO is giving OpenAI access to its data in the hope of developing drugs more quickly
Fortune via Yahoo Finance· 6 days agoGood morning from Geneva. If generative AI is going to be more than hype and hallucinations, the...
Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits
CNBC· 1 day agoCompany logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain...
Sanofi's Dupixent Drug Review Date Extended by Three Months in the U.S.
Market Watch· 4 days agoFrench pharmaceutical company Sanofi said that the priority review date in the U.S. for its chronic obstructive pulmonary disease treatment, Dupixent has been extended, but ...
